Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000357995

Medchemexpress LLC Tacedinaline | 112522-64-2 | 99.3% | C15H15N3O2 | 200 MG
SDP

Supplier:  Medchemexpress LLC HY50934200MG

Encompass_Preferred

Tacedinaline (N-acetyldinaline) is a potent inhibitor of histone deacetylase (HDAC), demonstrating significant antitumor activity in preclinical models. Its mechanism involves the inhibition of histone deacetylation and cell cycle arrest. This compound exhibits marked synergism when combined with antineoplastic agents like gemcitabine in non-small cell lung cancer cell lines.

  • Inhibits histone deacetylase (HDAC 1, 2, and 3)
  • Shows broad antitumor activity
  • Induces cell cycle arrest
  • Synergistic with gemcitabine in non-small cell lung cancer
  • Inhibits mitogen-stimulated blood lymphocyte proliferation

Catalog No. 50-003-57995


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.